Press ReleaseCardiawave annonce les résultats positifs à 12 mois de ses études “Valvosoft® FIM Study” et « Valvosoft® Pivotal Study » à l’EuroPCR! May 23, 2025 READ MORE
Press ReleaseCardiawave Announces Positive 12-Month Results from Its “Valvosoft® FIM Study” and “Valvosoft® Pivotal Study”, presented at EuroPCR! May 23, 2025 READ MORE
Press ReleaseCardiawave announces positive 6-month data from its Valvosoft Pivotal Study, presented at TCT Conference ! Oct 29, 2024 READ MORE
EventsJournée Mondiale du Coeur: Pr Damien Metz considère la technologie Valvosoft® comme un complément potentiel aux moyens thérapeutiques existants Sep 30, 2024 READ MORE
